UPDATE 2-AstraZeneca faces falling profit while awaits key drug data
* All eyes on mid-year results from lung cancer trial (Adds shares, further details on cancer drug competition) [Source]
Publication Date:Origin: reuters.com
Category: marketsNews
Topics: cancer, competition), details, further, shares, (Adds, trial, results, mid-year, awaits, while, profit, falling, faces, 2-AstraZeneca, UPDATE
Source: http://feeds.reuters.com/~r/news/usmarkets/~3/q6kj4VH2kac/astrazeneca-results-idUSL5N1FN1GV